Compare ROIV & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROIV | NNN |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 8.5B |
| IPO Year | 2021 | 1995 |
| Metric | ROIV | NNN |
|---|---|---|
| Price | $27.41 | $42.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | $27.56 | ★ $44.17 |
| AVG Volume (30 Days) | ★ 4.4M | 1.2M |
| Earning Date | 02-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | $29,053,000.00 | ★ $926,213,000.00 |
| Revenue This Year | N/A | $5.36 |
| Revenue Next Year | $594.84 | $5.14 |
| P/E Ratio | ★ N/A | $20.28 |
| Revenue Growth | N/A | ★ 6.55 |
| 52 Week Low | $8.73 | $35.80 |
| 52 Week High | $30.33 | $46.03 |
| Indicator | ROIV | NNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 31.88 |
| Support Level | $26.94 | $41.73 |
| Resistance Level | $27.94 | $43.18 |
| Average True Range (ATR) | 0.88 | 0.74 |
| MACD | -0.35 | -0.44 |
| Stochastic Oscillator | 20.32 | 7.93 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
NNN REIT Inc is a real estate investment trust that acquires, owns, invests in, and develops high-quality properties mainly leased under long-term net leases with minimal capital expenditure requirements. The company focuses mainly on retail properties, with a portfolio including convenience stores, automotive service properties, restaurants, theatres, entertainment venues, dealerships, and other retail-related assets. Primary business objectives emphasize retail properties, and it may invest in a wide variety of property and tenant types, leases, mortgages, loans secured by personal property, loans secured by partnership or membership interests, and securities of other REITs or other issuers.